Live Breaking News & Updates on Therapeutics Profile
Stay updated with breaking news from Therapeutics profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
State of Alaska Department of Revenue trimmed its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Rating) by 2.8% in the 1st quarter, HoldingsChannel reports. The fund owned 19,809 shares of the biopharmaceutical company’s stock after selling 570 shares during the quarter. State of Alaska Department of Revenue’s holdings in Halozyme Therapeutics were worth $789,000 […] ....
Pinnacle Associates Ltd. reduced its position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Rating) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,803 shares of the biopharmaceutical company’s stock after selling 5,156 shares during the period. Pinnacle Associates Ltd.’s holdings […] ....
State of New Jersey Common Pension Fund D grew its holdings in Nektar Therapeutics (NASDAQ:NKTR – Get Rating) by 18.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 238,019 shares of the biopharmaceutical company’s stock after buying an additional 36,578 shares during the quarter. State of New Jersey Common Pension Fund D’s […] ....
Strs Ohio trimmed its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) by 14.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,600 shares of the company’s stock after selling 800 shares during the quarter. Strs Ohio’s holdings in Axsome Therapeutics were worth $173,000 at the end of the most recent […] ....
Brown Advisory Inc. acquired a new position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 12,914 shares of the company’s stock, valued at approximately $397,000. Other institutional investors and hedge […] ....